Schizophrenia, Paranoid clinical trials
The registry lists 41 studies for Schizophrenia, Paranoid across more than 10 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Schizophrenia, Paranoid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (2) · VA Office of Research and Development (2) · Mental Health Services in the Capital Region, Denmark (2) · Organon and Co (2) · Philipps University Marburg (2) · Centre for Addiction and Mental Health (2) · Merck Sharp & Dohme LLC (2) · University of Pittsburgh (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care · University of Jyvaskyla
- Dec 2026Tau Biomarkers in Late-onset Psychosis (LOP) · Jeremy Koppel
- Jun 2027Shared Decision Making for Antipsychotic Medications · New York State Psychiatric Institute
- Jun 2027Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services · Beth Israel Deaconess Medical Center
Who these studies take
Of the 6 Schizophrenia, Paranoid studies recruiting now, 3 (50%) set no upper age limit and 2 (33%) stop at 75 or younger. 2 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 5 (83%) | 5 (83%) |
| 30 | 5 (83%) | 5 (83%) |
| 40 | 4 (67%) | 4 (67%) |
| 50 | 3 (50%) | 3 (50%) |
| 65 | 4 (67%) | 4 (67%) |
| 75 | 4 (67%) | 4 (67%) |
| 85 | 4 (67%) | 4 (67%) |
Across all 41 studies, recruiting or not: 71% stop at 75 or younger and 59% at 65; 29% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Schizophrenia, Paranoid studies take
Of 14 interventional studies with no phase under Schizophrenia, Paranoid, half reached primary completion within 35 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 35 mo10–47 · 14 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 41 of 41. search them.
- Tau Biomarkers in Late-onset Psychosis (LOP)RecruitingNCT063363821 country
- FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisRecruitingNCT07645443Not applicable1 country
- Enhancing Veteran-Clinical Collaboration in VA PRRCsRecruitingNCT06898879Not applicable1 country
- Shared Decision Making for Antipsychotic MedicationsNot yet recruitingNCT05416658Not applicable
- Biomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesRecruitingNCT067403831 country
- Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System InvolvementEnrolling by invitationNCT04323566Phase 21 country
- The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric CareRecruitingNCT06005766Not applicable1 country
- Integrated Care in Psychotic Disorders With Severe Mental IllnessRecruitingNCT01888627Not applicable1 country
- Young Adults With Violent Behavior During Early Psychosis (Aim 2)CompletedNCT05756855Not applicable1 country
- The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode PsychosisCompletedNCT04916626Not applicable1 country
- Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".CompletedNCT04902066Not applicable1 country
- SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial DisabilitiesCompletedNCT06007105Not applicable4 countries
- Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental IllnessCompletedNCT04324944Not applicable1 country
- Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum DisordersStatus unknownNCT06423651Not applicable1 country
- Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)CompletedNCT01190267Phase 3
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)CompletedNCT01190254Phase 3
- Improving Work Outcome for People With Severe Mental IllnessCompletedNCT01722344Not applicable1 country
- Feasibility of a Novel Process-based Treatment for Patients With PsychosisCompletedNCT04874974Not applicable1 country
- Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.CompletedNCT00716755Not applicable1 country
- Research Into Antipsychotic Discontinuation and Reduction TrialCompletedNCT03559426Phase 41 country
- The Efficacy of Using a Smartphone App to Support Shared Decision Making in People With a Diagnosis of SchizophreniaCompletedNCT03554655Not applicable1 country
- Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic DisordersCompletedNCT04783285Not applicable1 country
- A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 41 country
- D-Cycloserine Augmentation of Cognitive Behavioral Therapy for DelusionsCompletedNCT01981759Phase 41 country
- Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With SchizophreniaCompletedNCT02787122Not applicable1 country
- Quantitative Investigation of Environment and ParticipationStatus unknownNCT041069601 country
- Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)CompletedNCT01822418Phase 41 country
- Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for SchizophreniaCompletedNCT00742079Phase 41 country
- Evaluation of the Texas Wellness Incentives and Navigation (WIN) ProjectCompletedNCT02440906Not applicable1 country
- Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes MellitusCompletedNCT002228071 country
- Multi-disciplinary Treatment for Patients Experiencing First Episode of PsychosisCompletedNCT01216891Not applicable1 country
- Anticholinergic Burden in SchizophreniaTerminatedNCT00715377Not applicable1 country
- MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)CompletedNCT00482430Phase 2
- MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)CompletedNCT00506077Phase 2
- Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of SchizophreniaCompletedNCT01176721Phase 21 country
- Schizophrenic Patients Taking Part in Integrated Care ProgramTerminatedNCT006172141 country
- Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than RisperidoneStatus unknownNCT00563017Not applicable1 country
- Acceptance and Commitment Therapy for DelusionsCompletedNCT00657631Not applicable1 country
- Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisStatus unknownNCT00465920Phase 21 country
- Cognitive Determinants of Psychoeducation and Information in PsychosesStatus unknownNCT00646256Not applicable1 country
- Trial of Cognitive Behavioral Therapy for SchizophreniaStatus unknownNCT00300651Phase 31 country